NCT03113500 2025-11-14
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
City of Hope Medical Center
Phase 2 Active not recruiting
City of Hope Medical Center
University of Nebraska
Dana-Farber Cancer Institute
Rutgers, The State University of New Jersey